Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
<p>Abstract</p> <p>Background</p> <p>Indacaterol is a novel, inhaled, once-daily, ultra-long-acting β<sub>2</sub>-agonist for the treatment of chronic obstructive pulmonary disease (COPD). This randomized, double-blind study compared the bronchodilator effic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-10-01
|
| Series: | Respiratory Research |
| Online Access: | http://respiratory-research.com/content/11/1/135 |